EichorEICHOR
Study identifier: NCT04760626 Synced from ClinicalTrials.gov · August 04, 2026
● Completed

A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin Before

Condition: Diabetes Mellitus, Type 2  ·  Sponsor: Novo Nordisk A/S

PhasePhase 3
Planned participants1085
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

This study compares insulin icodec to different daily insulins in people with type 2 diabetes. The study will look at how well insulin icodec taken once weekly controls blood sugar compared to the insulins taken once daily. Participants will either get insulin icodec, that participants will have to inject once a week on the same day of the week, or a marketed insulin, that participants will have to inject once a day. Which treatment participants get is decided at random. The insulin is injected with a needle in a skin fold in the thigh, upper arm or stomach. Participants will measure their blood sugar every day. Participants will get a study phone to record safety data in the electronic diary (eDiary). If participants get a daily insulin they will record their insulin doses in the eDiary. If Participants get weekly insulin icodec, participants study phone will also have the DoseGuide App. The DoseGuide App gives dose recommendations based on their blood sugar and previous doses. Participants will record their insulin doses in the DoseGuide App. The study will last for about 1 year and 2 months. Participants will have 8 planned clinic visits with the study doctor. More visits will be planned to meet individual needs. At 6 clinic visits participants will have blood samples taken. Women cannot take part if pregnant, breast-feeding or plan to become pregnant during the study period.

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (311)

Univ of Alabama BirminghamBirmingham, Alabama, United States
Lakeview Clinical Research, LLCGuntersville, Alabama, United States
Pri Med Grp dba/Gil Ctr FamGilbert, Arizona, United States
Lynn Institute of the OzarksLittle Rock, Arkansas, United States
Anaheim Clinical Trials, LLCAnaheim, California, United States
Advanced Clinical Research/Rancho Paseo Medical GroupBanning, California, United States
American Clinical TrialsBuena Park, California, United States
San Fernando Valley Hlth Inst, LLCCanoga Park, California, United States
Med Center Medical ClinicCarmichael, California, United States
Headlands Research California, LLCEscondido, California, United States
Valley ResearchFresno, California, United States
Advanced Investigative Medicine, Inc.Hawthorne, California, United States

+ 299 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →